Felberg Craig
VP, R&D and Clinical Affairs at STAA
- Sold, on record
- $253k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jun 5, 2012
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- STAASTAAR SURGICAL COVP, R&D and Clinical Affairs
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale STAAPlan not statedMar 7 2011
Sold 1,900 shares at $5.75 ($11k)
Felberg Craig, VP, R&D and Clinical Affairs
Sold 2.4% of holdings ($454k position)77,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale STAAPlan not statedMar 2 +361 days
Sold 800 shares at $148.52 ($119k)
Felberg Craig, VP, R&D and Clinical Affairs
Sold 3.3% of holdings ($3.6M position)23,700 shares leftFiling
- 3 Form 4 sale STAAUnusualJun 5 +95 days
Sold 15,000 shares at $8.25 ($124k)
Felberg Craig, VP, R&D and Clinical Affairs
Sold 63.3% of holdings ($196k position)8,700 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2012 | STAA | VP, R&D and Clinical Affairs | Form 4 sale | 15,000 | $124k | 63.3% | Unusual | SEC |
| Mar 2, 2012 | STAA | VP, R&D and Clinical Affairs | Form 4 sale | 800 | $119k | 3.3% | Plan not stated | SEC |
| Mar 7, 2011 | STAA | VP, R&D and Clinical Affairs | Form 4 sale | 1,900 | $11k | 2.4% | Plan not stated | SEC |